# NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
> **NDA214628** · New Drug Application · Sponsor: LONG GROVE PHARMS · Approved 2022-10-06
## Drug
- **FDA Application Number:** NDA214628
- **Application type:** New Drug Application
- **Brand name:** NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
- **Generic name:** NOREPINEPHRINE BITARTRATE
- **Active ingredients:** NOREPINEPHRINE BITARTRATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** LONG GROVE PHARMS
- **Manufacturer:** Long Grove Pharmaceuticals, LLC
- **First approval:** 2022-10-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214628)
---
*AI Analytics · CC0 1.0*